Answered You can buy a ready-made answer or pick a professional tutor to order an original one.
Subject: The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancerFaculty: Medicine and healthcareLanguage: Engli
Subject: The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancerFaculty: Medicine and healthcareLanguage: English UKSize: 10 Pages (approx. 2,100 characters including spaces per page)
The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancer
A report of the statistical results is required.
The following formats apply when drawing up the solution sketch:
Side margin: top and bottom 2cm each, left 3cm, right 2cmPage numbers: bottom right; cover page: no page number; indexes: Roman numbering (starting with I)Font size and type in continuous text: 12 Pt Arial, justifiedLine spacing: 1.5 linesChapter headings: 14 Pt bold, then two lines apartSubchapter headings: 12 Pt bold, followed by one line spacingFootnote text: 10 Pt justified justified text, 1.0 lines, footnotes are placed in a vertical position
- @
- ANSWER
-
Tutor has posted answer for $100.00. See answer's preview
***** ** involved ***** nodes *** a significant role ** apredictive ********* for ******** ** neoadjuvant chemotherapy ** ******** with ************* ****** ** ** ********* to ********* the **** ** ***** ** ******** ***** ***** ** apredictive ********* *** response ** *********** chemotherapy ** ******** **** earlybreast ****** ******* ******** works have ********* **** ****** ****** *** Ki-67expression ** * ******* ********** ****** ********* ***** ** *** ****** ** * ************ for cancer ** *** ***** **** ***** ** ***** ***** confirms ***** conversion Itis *** * ************ **** ***** is a high association ******* **** Ki-67 **** **** pCRrate **** ********* that **** **** ***** ** a ******** disease patients *** **** toachieve pCR ** *********** ************ maintain * ****** prognosis ** ** ******** *********** a subset of ******** among ********* using **** expression *** node ******* positive ****** ****** **** whom adjuvant ********************* ** addition ** ************** ***** ************ **** ********* ** *** cell *************** ****** *** ********* but *** in ********** ***** *** *** *********** **** considered a ************* marker close to ********* types Several studies **** ********* **** the ***** ***** *************************** *** * relation ** **** ************* ***** is * *********** relation ******* ***** ** ******** ***** ***** **** *** ********** **** ***** ** *** ****** being * ************ *** ****** ****** Also ******* ******** ***** to note ** **** ***** ** ** ********************** ******* Ki-67 ** involved ***** ***** and *** ******* ***** ** ********* *** * substantial correlation **** pCRTherefore **** ***** ****** ** ****** ****** are ********** a **** **************** ***** ********** * positive predictive ************** for response tochemotherapy Neoadjuvant ************ ****** ** determinable ****** * short ************ *** ******** significant ** *********** *** effective ******* ** ***** forparticular ********** ********** *********** **** ** ****** *** ******* *** efficacy ********** ******* ** prognostic and ********** ******* Postoperative ******** *************** * survival advantage ******** ** neoadjuvant ************ ***** **** notHowever ***** ** a ********** improved ******* ******** *** ************ survival ********** who have ******** *** **** in patients **** ******** ******
